Response: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus ( 2019;43:582-9).
作者信息
Hwang You Cheol
机构信息
Division of Endocrinology and Metabolism, Department of Medicine, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, Korea.
出版信息
Diabetes Metab J. 2019 Dec;43(6):915-916. doi: 10.4093/dmj.2019.0213.
Abstract
摘要
相似文献
1
Response: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus ( 2019;43:582-9).回应：瑞舒伐他汀单药20毫克与瑞舒伐他汀5毫克和依折麦布10毫克联合治疗对2型糖尿病患者血脂参数的疗效比较（2019年；43:582 - 589）
Diabetes Metab J. 2019 Dec;43(6):915-916. doi: 10.4093/dmj.2019.0213.
2
Letter: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus ( 2019;43:582-9).信函：瑞舒伐他汀单药治疗20毫克与瑞舒伐他汀5毫克和依折麦布10毫克联合治疗对2型糖尿病患者血脂参数的疗效比较（2019年；43卷：582 - 589页）
Diabetes Metab J. 2019 Dec;43(6):909-910. doi: 10.4093/dmj.2019.0205.
3
Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus.瑞舒伐他汀单药20mg与瑞舒伐他汀5mg及依折麦布10mg联合治疗对2型糖尿病患者血脂参数的疗效比较
Diabetes Metab J. 2019 Oct;43(5):582-589. doi: 10.4093/dmj.2018.0124. Epub 2019 Jan 16.
4
Efficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia.依折麦布与瑞舒伐他汀联合治疗与瑞舒伐他汀单药治疗原发性高胆固醇血症患者的疗效和安全性。
Clin Ther. 2018 Jun;40(6):993-1013. doi: 10.1016/j.clinthera.2018.04.015. Epub 2018 May 30.
5
A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial.一项 III 期、多中心、随机、双盲、阳性对照临床试验，旨在比较依折麦布和瑞舒伐他汀联合治疗与瑞舒伐他汀单药治疗在高胆固醇血症患者中的疗效和安全性：I-ROSETTE（Ildong 瑞舒伐他汀和依折麦布治疗高胆固醇血症）随机对照试验。
Clin Ther. 2018 Feb;40(2):226-241.e4. doi: 10.1016/j.clinthera.2017.12.018.
6
Combination Therapy of Rosuvastatin and Ezetimibe in Patients with High Cardiovascular Risk.瑞舒伐他汀与依折麦布联合治疗心血管高危患者
Clin Ther. 2017 Jan;39(1):107-117. doi: 10.1016/j.clinthera.2016.11.014. Epub 2016 Dec 19.
7
Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients.依折麦布联合瑞舒伐他汀与瑞舒伐他汀单药滴定疗法在HIV阳性患者中的降脂疗效及安全性比较
Lipids Health Dis. 2015 Jun 19;14:57. doi: 10.1186/s12944-015-0054-x.
8
Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study).瑞舒伐他汀40毫克单药治疗或与依折麦布联合治疗心血管疾病高危患者的疗效与安全性（EXPLORER研究结果）
Am J Cardiol. 2007 Mar 1;99(5):673-80. doi: 10.1016/j.amjcard.2006.10.022. Epub 2007 Jan 4.
9
A randomized, controlled comparison of different intensive lipid-lowering therapies in Chinese patients with non-ST-elevation acute coronary syndrome (NSTE-ACS): Ezetimibe and rosuvastatin versus high-dose rosuvastatin.中国非ST段抬高型急性冠状动脉综合征（NSTE-ACS）患者不同强化降脂治疗的随机对照比较：依折麦布与瑞舒伐他汀联合应用对比大剂量瑞舒伐他汀。
Int J Cardiol. 2017 May 15;235:49-55. doi: 10.1016/j.ijcard.2017.02.099. Epub 2017 Feb 23.
10
引用本文的文献
1
Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study.瑞舒伐他汀/依折麦布联合治疗与瑞舒伐他汀单药治疗对2型糖尿病患者脂蛋白的疗效及安全性比较：多中心随机对照研究
Diabetes Ther. 2020 Apr;11(4):859-871. doi: 10.1007/s13300-020-00778-1. Epub 2020 Feb 17.
本文引用的文献
1
Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus.瑞舒伐他汀单药20mg与瑞舒伐他汀5mg及依折麦布10mg联合治疗对2型糖尿病患者血脂参数的疗效比较
Diabetes Metab J. 2019 Oct;43(5):582-589. doi: 10.4093/dmj.2018.0124. Epub 2019 Jan 16.
2
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会/美国心脏协会成人降低动脉粥样硬化性心血管风险的血胆固醇治疗指南：美国心脏病学会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934. doi: 10.1016/j.jacc.2013.11.002. Epub 2013 Nov 12.
3
Demystifying the management of hypertriglyceridaemia.揭开高甘油三酯血症管理的神秘面纱。
Nat Rev Cardiol. 2013 Nov;10(11):648-61. doi: 10.1038/nrcardio.2013.140. Epub 2013 Sep 24.
Zotero 插件